Search

everythinglearnresearchcommunity

for

Search:↓

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

A reliable method was developed to measure Minoxidil and Tofacitinib in gel for hair loss treatment.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Some gonadal hormone drugs can block filovirus entry into cells.

Etanercept improved arthritis and psoriasis but caused hair loss, which healed after switching to sulfasalazine.

Turpentine ointment is effective and safe for treating folliculitis.

Cetirizine is effective and safe for treating various allergies, with personalized dosing improving its use.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

11-oxyandrogens are linked to excess hair growth in PCOS, but don't help diagnose it.

Upadacitinib effectively treats psoriasis and lichen planus together.

TSPO might help treat anxiety and depression.

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

Balancing lipophilicity and solubility is key for effective and safe ketorolac prodrugs.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Finasteride increases CD8+ T cells in BPH tissues.

The doxazosin plus tamsulosin combination improved symptoms effectively with fewer side effects.

Increasing TSPO in the brain reduces anxiety and depression.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Topical corticosteroids are effective for skin conditions but can have side effects.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.